Navidea Biopharmaceuticals Cash from Financing (TTM) Insights

Navidea Biopharmaceuticals Inc (NAVB)

0.0342 -0.01 (-14.50%) USD | OTCM | Apr 16, 15:02

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1993. Upgrade now.

Date	Value
September 30, 2023	0.9958M
June 30, 2023	7.394M
March 31, 2023	7.281M
December 31, 2022	7.142M
September 30, 2022	7.114M
June 30, 2022	3.112M
March 31, 2022	3.802M
December 31, 2021	12.11M
September 30, 2021	13.82M
June 30, 2021	16.56M
March 31, 2021	17.61M
December 31, 2020	10.21M
September 30, 2020	9.620M
June 30, 2020	4.596M
March 31, 2020	6.792M
December 31, 2019	6.156M
September 30, 2019	5.081M
June 30, 2019	8.081M
March 31, 2019	-4.497M
December 31, 2018	-4.548M
September 30, 2018	-4.531M
June 30, 2018	-7.496M
March 31, 2018	-0.3549M
December 31, 2017	-61.00M
September 30, 2017	-62.46M

Date	Value
June 30, 2017	-65.42M
March 31, 2017	-69.90M
December 31, 2016	-9.144M
September 30, 2016	-7.616M
June 30, 2016	-4.944M
March 31, 2016	17.29M
December 31, 2015	20.79M
September 30, 2015	20.74M
June 30, 2015	21.06M
March 31, 2015	3.459M
December 31, 2014	3.192M
September 30, 2014	3.210M
June 30, 2014	32.01M
March 31, 2014	55.48M
December 31, 2013	60.72M
September 30, 2013	66.04M
June 30, 2013	36.80M
March 31, 2013	13.56M
December 31, 2012	5.070M
September 30, 2012	6.323M
June 30, 2012	7.511M
March 31, 2012	5.933M
December 31, 2011	11.08M
September 30, 2011	9.986M
June 30, 2011	9.151M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

0.9958M

Minimum

Sep 2023

17.61M

Maximum

Mar 2021

8.193M

Average

7.211M

Median

Cash from Financing (TTM) Benchmarks